ARRDC5 inhibitors are a class of small molecules or compounds that specifically target and inhibit the activity of the Arrestin Domain-Containing Protein 5 (ARRDC5). ARRDC5 belongs to the family of arrestin proteins, which are known for their involvement in regulating G protein-coupled receptors (GPCRs) and other cellular processes. This particular protein is part of a subgroup called α-arrestins, which are associated with endocytosis and trafficking of membrane proteins. Inhibition of ARRDC5 alters these pathways by preventing the recruitment of key cellular machinery involved in internalizing and recycling surface proteins. This can have significant effects on intracellular signaling networks and overall cell homeostasis, as ARRDC5 plays a critical role in regulating protein sorting and degradation.
The chemical inhibitors of ARRDC5 are designed to interfere with the protein's ability to interact with specific molecular partners, such as ubiquitin ligases or GPCRs. By blocking these interactions, ARRDC5 inhibitors can modulate cellular signaling pathways, including those involved in protein ubiquitination and degradation processes. Furthermore, the inhibition of ARRDC5 can lead to changes in membrane protein turnover and trafficking, potentially impacting cell surface receptor levels and other proteins vital to cellular communication and function. Structural studies of ARRDC5 and its inhibitors often focus on identifying binding sites and the precise molecular mechanisms by which inhibition is achieved, providing insights into how these inhibitors exert their effects at the biochemical level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Exo1 | 461681-88-9 | sc-200752 sc-200752A | 10 mg 50 mg | $84.00 $297.00 | 4 | |
Exo1 inhibits the exosome complex, which is involved in mRNA degradation, including mRNAs that encode arrestin domain containing 5, reducing its production. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
Lactacystin inhibits the proteasome, which could lead to increased degradation of misfolded arrestin domain containing 5 proteins before they become functional. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 inhibits the vacuolar H+-ATPase (V-ATPase), potentially leading to lysosomal dysfunction and subsequent degradation of arrestin domain containing 5. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 inhibits the proteasome, potentially increasing the degradation of misfolded or damaged arrestin domain containing 5 proteins. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine inhibits lysosomal acidification, which can disrupt the lysosomal degradation pathway, potentially leading to the accumulation of defective arrestin domain containing 5. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
E-64 inhibits cysteine proteases, which may lead to an accumulation of defective arrestin domain containing 5 proteins by preventing their degradation. | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $73.00 $148.00 $316.00 $499.00 $1427.00 $101.00 | 19 | |
Leupeptin inhibits lysosomal proteases, which could lead to an accumulation of non-functional arrestin domain containing 5 proteins due to impaired degradation. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin disrupts Golgi function, which can lead to improper glycosylation and misfolding of arrestin domain containing 5, resulting in its functional inhibition. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Puromycin causes premature chain termination during protein synthesis, leading to the production of truncated, non-functional arrestin domain containing 5 proteins. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits eukaryotic protein synthesis, leading to a decrease in overall protein levels, including potentially non-functional arrestin domain containing 5. | ||||||